Applied Therapeutics Inc. reports $10.1 million Q1 loss

Applied Therapeutics Inc. [APLT] has reported fiscal Q1 loss of $10.10 million.

On a per-share basis, the DE based company said its diluted earnings are $0.18.

The Pharmaceutical Preparations firm posted revenue of $10.70 million in this period.

Also Read:

• Applied Therapeutics Reports First Quarter 2023 Financial Results
• Applied Therapeutics Announces Clinical Benefit of Govorestat (AT-007) in ACTION-Galactosemia ...
• Applied Therapeutics, Inc. Announces $30 Million Private Placement of Equity
• SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Applied Therapeutics, Inc. (NASDAQ: APLT)
• Applied Therapeutics Reports Fourth Quarter and Year-end 2022 Financial Results